Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Uges

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|July 19, 1989
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell lineH Timmer-Bosscha, G A Hospers, C Meijer, et al.
International Journal of Cancer|June 19, 1991
In vitro and in vivo modulation of multi-drug resistance with amiodaroneW T van der Graaf, E G de Vries, D R Uges, et al.
Cancer Research|December 1, 1988
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitroG A Hospers, N H Mulder, B de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic studyE F Smit, P H Willemse, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicinE G de Vries, J Greidanus, N H Mulder, et al.
British Journal of Cancer|February 1, 1993
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 daysJ A Gietema, E G de Vries, D T Sleijfer, et al.
Early Human Development|September 25, 2009
Neurophysiological evaluation in children with Friedreich's ataxiaD A Sival, G J du Marchie Sarvaas, O F Brouwer, et al.
Tijdschrift Voor Diergeneeskunde|July 1, 1987
[Regional isolation perfusion with cisplatinum in dogs with osteosarcoma of an extremity]J de Vries, H Schraffordt Koops, J W Oosterhuis, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|July 19, 1989
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell lineH Timmer-Bosscha, G A Hospers, C Meijer, et al.
International Journal of Cancer|June 19, 1991
In vitro and in vivo modulation of multi-drug resistance with amiodaroneW T van der Graaf, E G de Vries, D R Uges, et al.
Cancer Research|December 1, 1988
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitroG A Hospers, N H Mulder, B de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic studyE F Smit, P H Willemse, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicinE G de Vries, J Greidanus, N H Mulder, et al.
British Journal of Cancer|February 1, 1993
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 daysJ A Gietema, E G de Vries, D T Sleijfer, et al.
Early Human Development|September 25, 2009
Neurophysiological evaluation in children with Friedreich's ataxiaD A Sival, G J du Marchie Sarvaas, O F Brouwer, et al.
Tijdschrift Voor Diergeneeskunde|July 1, 1987
[Regional isolation perfusion with cisplatinum in dogs with osteosarcoma of an extremity]J de Vries, H Schraffordt Koops, J W Oosterhuis, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
Pageof 9